Skip to main content

Closed

NVCT: Nuvectis Pharma, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-198.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio2.27×

Nuvectis Pharma, Inc.

NVCTNASDAQ Capital Market·USD·Closed

Nuvectis Pharma, Inc.

NVCTNASDAQ·USD·Closed

$21.52

−5.45%

$21.52

−$1.24 (5.45%)

52W Range

67thpctl

Volume

0.54×avg

Mkt Cap

571.06MUSD

P/E

-16.4TTM

Div Yield

–ann

52W Range

67thpctl

Volume

0.54×avg

Market Cap

571.06MUSD

P/E Ratio

-16.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings